|
Date |
Name |
Title |
Volume |
Trade Price |
Holding Change |
|
4/4/2012
|
ALEXANDER SUSAN H
|
EVP, General Counsel
|
-3,236
|
$130.00
|
-24.11%
|
|
4/4/2012
|
ALEXANDER SUSAN H
|
EVP, General Counsel
|
3,236
|
$44.73
|
31.77%
|
|
3/8/2012
|
PANGIA ROBERT W
|
Director
|
-5,000
|
$120.00
|
-23.17%
|
|
3/8/2012
|
PANGIA ROBERT W
|
Director
|
5,000
|
$34.34
|
30.16%
|
|
3/8/2012
|
PANGIA ROBERT W
|
Director
|
-2,500
|
$120.00
|
-13.10%
|
|
3/8/2012
|
PANGIA ROBERT W
|
Director
|
2,500
|
$36.94
|
15.08%
|
|
2/29/2012
|
Gagnon Robert E.
|
Vice President, Finance
|
-357
|
$115.51
|
-8.20%
|
|
2/29/2012
|
Gagnon Robert E.
|
Vice President, Finance
|
-360
|
$115.51
|
-7.63%
|
|
2/28/2012
|
Gagnon Robert E.
|
Vice President, Finance
|
-835
|
$115.03
|
-15.04%
|
|
2/27/2012
|
ALEXANDER SUSAN H
|
EVP, General Counsel
|
-2,117
|
$115.43
|
-17.21%
|
|
2/27/2012
|
ALEXANDER SUSAN H
|
EVP, General Counsel
|
-2,138
|
$115.43
|
-14.81%
|
|
2/24/2012
|
ALEXANDER SUSAN H
|
EVP, General Counsel
|
-1,739
|
$115.53
|
-9.06%
|
|
2/24/2012
|
ALEXANDER SUSAN H
|
EVP, General Counsel
|
-406
|
$115.53
|
-2.33%
|
|
2/24/2012
|
ALEXANDER SUSAN H
|
EVP, General Counsel
|
-1,294
|
$116.39
|
-7.59%
|
|
2/24/2012
|
ALEXANDER SUSAN H
|
EVP, General Counsel
|
-1,307
|
$116.39
|
-8.30%
|
|
2/24/2012
|
Cox John
|
EVP Pharmaceutical Oper & Tech
|
-785
|
$116.39
|
-5.49%
|
|
2/24/2012
|
Cox John
|
EVP Pharmaceutical Oper & Tech
|
-793
|
$116.39
|
-5.87%
|
|
2/24/2012
|
Gagnon Robert E.
|
Vice President, Finance
|
1,054
|
$49.65
|
17.91%
|
|
2/24/2012
|
Gagnon Robert E.
|
Vice President, Finance
|
-1,054
|
$115.53
|
-15.19%
|
|
2/24/2012
|
Gagnon Robert E.
|
Vice President, Finance
|
-166
|
$116.39
|
-2.82%
|
|
2/24/2012
|
Gagnon Robert E.
|
Vice President, Finance
|
-168
|
$116.39
|
-2.94%
|
|
2/24/2012
|
Clancy Paul J
|
Executive VP and CFO
|
-1,386
|
$116.39
|
-5.25%
|
|
2/24/2012
|
Clancy Paul J
|
Executive VP and CFO
|
-1,400
|
$116.39
|
-5.60%
|
|
2/23/2012
|
ALEXANDER SUSAN H
|
EVP, General Counsel
|
-1,413
|
$116.70
|
-6.86%
|
|
2/23/2012
|
Cox John
|
EVP Pharmaceutical Oper & Tech
|
-1,085
|
$116.70
|
-7.06%
|
|
2/23/2012
|
Gagnon Robert E.
|
Vice President, Finance
|
-388
|
$116.70
|
-6.19%
|
|
2/23/2012
|
Clancy Paul J
|
Executive VP and CFO
|
-1,786
|
$116.70
|
-6.34%
|
|
2/14/2012
|
Gagnon Robert E.
|
Vice President, Finance
|
-560
|
$118.61
|
-9.98%
|
|
2/14/2012
|
Kingsley Stuart A
|
EVP, Global Comm. Operations
|
-1,247
|
$118.61
|
-100.00%
|
|
2/13/2012
|
ALEXANDER SUSAN H
|
EVP, General Counsel
|
-2,842
|
$118.01
|
-14.49%
|
|
2/10/2012
|
SCANGOS GEORGE A
|
Chief Executive Officer
|
-7,007
|
$118.14
|
-9.56%
|
|
2/9/2012
|
Kingsley Stuart A
|
EVP, Global Comm. Operations
|
-579
|
$117.78
|
-31.71%
|
|
2/9/2012
|
Cox John
|
EVP Pharmaceutical Oper & Tech
|
-1,504
|
$117.78
|
-10.53%
|
|
2/9/2012
|
Gagnon Robert E.
|
Vice President, Finance
|
-301
|
$117.78
|
-5.09%
|
|
2/9/2012
|
ALEXANDER SUSAN H
|
EVP, General Counsel
|
-1,257
|
$117.78
|
-6.02%
|
|
2/9/2012
|
Clancy Paul J
|
Executive VP and CFO
|
-1,957
|
$117.78
|
-7.57%
|
|
2/6/2012
|
Kingsley Stuart A
|
EVP, Global Comm. Operations
|
-3,110
|
$121.03
|
-100.00%
|
|
2/1/2012
|
Clancy Paul J
|
Executive VP and CFO
|
13,000
|
$43.50
|
61.41%
|
|
2/1/2012
|
Clancy Paul J
|
Executive VP and CFO
|
8,400
|
$67.57
|
24.58%
|
|
2/1/2012
|
Clancy Paul J
|
Executive VP and CFO
|
-13,000
|
$120.00
|
-30.54%
|
|
2/1/2012
|
Clancy Paul J
|
Executive VP and CFO
|
-8,400
|
$120.00
|
-28.41%
|
|
2/1/2012
|
WILLIAMS DOUGLAS E
|
EVP Research & Development
|
-1,656
|
$121.26
|
-29.77%
|
|
2/1/2012
|
Holtzman Steven H
|
EVP Corp Devel and Strategy
|
-1,658
|
$121.26
|
-32.14%
|
|
2/1/2012
|
Granata Francesco
|
EVP Global Commercial Operatio
|
-1,669
|
$121.26
|
-32.11%
|
|
2/1/2012
|
Kingsley Stuart A
|
EVP, Global Comm. Operations
|
-1,477
|
$121.26
|
-32.20%
|
|
2/1/2012
|
LEAMING NANCY
|
Director
|
5,700
|
$59.17
|
89.98%
|
|
2/1/2012
|
LEAMING NANCY
|
Director
|
-5,700
|
$120.00
|
-47.36%
|
|
1/20/2012
|
LEAMING NANCY
|
Director
|
3,000
|
$55.97
|
47.36%
|
|
1/20/2012
|
LEAMING NANCY
|
Director
|
-3,000
|
$118.00
|
-32.14%
|
|
1/6/2012
|
Rowinsky Eric K
|
Director
|
-11,667
|
$116.00
|
-56.09%
|
|
1/6/2012
|
Rowinsky Eric K
|
Director
|
11,667
|
$59.82
|
127.72%
|
|
1/6/2012
|
Rowinsky Eric K
|
Director
|
-1,325
|
$116.00
|
-12.67%
|
|
1/6/2012
|
Rowinsky Eric K
|
Director
|
1,325
|
$59.82
|
14.50%
|
|
1/6/2012
|
LEAMING NANCY
|
Director
|
-3,000
|
$116.00
|
-32.14%
|
|
1/6/2012
|
LEAMING NANCY
|
Director
|
3,000
|
$55.97
|
47.36%
|
|
1/3/2012
|
Clancy Paul J
|
Executive VP and CFO
|
-5,574
|
$112.69
|
-20.84%
|
|
1/3/2012
|
Clancy Paul J
|
Executive VP and CFO
|
-14,670
|
$112.22
|
-35.42%
|
|
1/3/2012
|
LEAMING NANCY
|
Director
|
-4,000
|
$114.00
|
-38.70%
|
|
1/3/2012
|
LEAMING NANCY
|
Director
|
4,000
|
$55.97
|
63.14%
|
|
12/19/2011
|
SHERWIN STEPHEN A
|
Director
|
-2,500
|
$110.88
|
-27.37%
|
|
12/6/2011
|
Gagnon Robert E.
|
Chief Acct Officer VP & Contr
|
-795
|
$112.31
|
-13.60%
|
|
12/1/2011
|
Gagnon Robert E.
|
Chief Acct Officer VP & Contr
|
-371
|
$116.48
|
-5.97%
|
|
11/9/2011
|
Gagnon Robert E.
|
Chief Acct Officer VP & Contr
|
-796
|
$112.04
|
-11.35%
|
|
11/2/2011
|
Gagnon Robert E.
|
Chief Acct Officer VP & Contr
|
-371
|
$113.43
|
-5.03%
|
|
11/1/2011
|
Cox John
|
EVP Pharmaceutical Oper & Tech
|
2,175
|
$72.87
|
22.68%
|
|
11/1/2011
|
Cox John
|
EVP Pharmaceutical Oper & Tech
|
-2,175
|
$114.37
|
-18.49%
|
|
10/5/2011
|
Gagnon Robert E.
|
Chief Acct Officer VP & Contr
|
-252
|
$97.66
|
-3.30%
|
|
10/3/2011
|
Gagnon Robert E.
|
Chief Acct Officer VP & Contr
|
-778
|
$92.55
|
-9.25%
|
|
10/3/2011
|
Gagnon Robert E.
|
Chief Acct Officer VP & Contr
|
778
|
$49.59
|
10.19%
|
|
10/1/2011
|
Gagnon Robert E.
|
Chief Acct Officer VP & Contr
|
-118
|
$93.15
|
-1.52%
|
|
9/27/2011
|
YOUNG WILLIAM
|
Director
|
12,500
|
$47.55
|
46.54%
|
|
9/27/2011
|
YOUNG WILLIAM
|
Director
|
3,125
|
$46.99
|
7.94%
|
|
9/27/2011
|
YOUNG WILLIAM
|
Director
|
5,950
|
$52.22
|
14.01%
|
|
9/27/2011
|
YOUNG WILLIAM
|
Director
|
5,700
|
$59.17
|
11.77%
|
|
9/27/2011
|
YOUNG WILLIAM
|
Director
|
5,975
|
$53.43
|
11.04%
|
|
9/27/2011
|
YOUNG WILLIAM
|
Director
|
-33,250
|
$96.14
|
-55.32%
|
|
9/16/2011
|
LEAMING NANCY
|
Director
|
-3,085
|
$100.00
|
-32.75%
|
|
9/1/2011
|
YOUNG WILLIAM
|
Director
|
10,000
|
$34.34
|
37.23%
|
|
9/1/2011
|
YOUNG WILLIAM
|
Director
|
12,500
|
$36.94
|
33.91%
|
|
9/1/2011
|
YOUNG WILLIAM
|
Director
|
12,500
|
$66.29
|
25.32%
|
|
9/1/2011
|
YOUNG WILLIAM
|
Director
|
-35,000
|
$95.00
|
-56.58%
|
|
8/29/2011
|
Posner Brian S
|
Director
|
15,000
|
$71.38
|
118.76%
|
|
8/29/2011
|
Posner Brian S
|
Director
|
-15,000
|
$92.53
|
-54.29%
|
|
8/29/2011
|
YOUNG WILLIAM
|
Director
|
10,000
|
$68.15
|
37.23%
|
|
8/29/2011
|
YOUNG WILLIAM
|
Director
|
-10,000
|
$92.58
|
-27.13%
|
|
8/2/2011
|
ALEXANDER SUSAN H
|
EVP, General Counsel
|
-1,165
|
$102.04
|
-6.43%
|
|
8/1/2011
|
Clancy Paul J
|
Executive VP and CFO
|
-835
|
$102.90
|
-1.98%
|
|
8/1/2011
|
ALEXANDER SUSAN H
|
EVP, General Counsel
|
-835
|
$102.90
|
-4.40%
|
|
7/20/2011
|
SCANGOS GEORGE A
|
Chief Executive Officer
|
-2,640
|
$105.98
|
-3.95%
|
|
7/20/2011
|
SCANGOS GEORGE A
|
Chief Executive Officer
|
-3,492
|
$106.90
|
-5.44%
|
|
7/20/2011
|
SCANGOS GEORGE A
|
Chief Executive Officer
|
-2,415
|
$105.94
|
-3.98%
|
|
7/20/2011
|
SCANGOS GEORGE A
|
Chief Executive Officer
|
-3,800
|
$106.88
|
-6.52%
|
|
7/15/2011
|
SCANGOS GEORGE A
|
Chief Executive Officer
|
-8,791
|
$104.00
|
-13.92%
|
|
7/15/2011
|
SCANGOS GEORGE A
|
Chief Executive Officer
|
-8,911
|
$104.00
|
-11.77%
|
|
7/14/2011
|
SCANGOS GEORGE A
|
Chief Executive Officer
|
-8,791
|
$104.00
|
-13.92%
|
|
7/1/2011
|
Granata Francesco
|
EVP Global Commercial Operatio
|
-2,901
|
$107.52
|
-100.00%
|
|
6/14/2011
|
LEAMING NANCY
|
Director
|
-2,300
|
$92.62
|
-19.62%
|
|
5/26/2011
|
LEAMING NANCY
|
Director
|
25,000
|
$55.97
|
283.45%
|
|
5/26/2011
|
LEAMING NANCY
|
Director
|
2,200
|
$55.97
|
6.51%
|
|
5/26/2011
|
LEAMING NANCY
|
Director
|
5,975
|
$53.43
|
16.59%
|